"We work to collaboratively discover and engineer novel antibody solutions as biological tools and next-generation therapeutics."
I joined Genentech as a Scientist in Fall 2014 in the Department of Antibody Engineering after completing graduate and postdoctoral studies in protein engineering focused on viral gene delivery and rationally designed antibodies. At Genentech, I enjoy working in the collaborative environment to discover novel biology and transformative drugs. We work to advance new therapies to patients by tackling challenging targets and engineering around drug delivery barriers.
My group seeks to discover and engineer novel antibody solutions as biological tools and next-generation therapeutics. We focus mainly on two areas: complex membrane proteins and engineered antibody formats.